| Financial Year |
March 31 2023 |
| Monetary Funds |
660,456,510.15 |
| Held-for-trading Financial Assets |
5,308,800.00 |
| Notes Receivable |
1,452,286.92 |
| Accounts Receivable |
275,809,683.86 |
| Advances to Suppliers |
102,579,409.40 |
| Other Receivables |
42,593,402.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,712,283.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
612,600,108.19 |
| Total Current Assets |
1,719,512,484.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
128,000,000.00 |
| Long-term Equity Investment |
50,932,855.04 |
| Investment Properties |
-- |
| Fixed Assetes |
225,343,121.46 |
| Under-construction Projects |
5,867,584.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
869,874,741.95 |
| R&D expenses |
-- |
| Goodwill |
327,866,930.16 |
| Long-Term Deferred and Prepaid Expenses |
4,518,488.94 |
| Deferred Income Tax Assets |
39,921,472.21 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,675,983,021.41 |
| Total Assets |
3,395,495,506.01 |
| Short-Term Loans |
2,739,724.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
38,548,760.95 |
| Accounts Received In Advance |
50,037.50 |
| Employee Compensation Payable |
8,140,835.29 |
| Taxes Payable |
28,508,788.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,659,898.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
243,514,431.06 |
| Other Current Liabilities |
22,461,236.03 |
| Sub-Total of Current Liabilities |
373,985,850.35 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
71,155,652.89 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
203,798,733.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
290,109,354.32 |
| Total Liabilities |
664,095,204.67 |
| Paid-In Capital(Or Share Stock) |
1,067,324,206.00 |
| Capital Surplus |
2,547,836,128.69 |
| Surplus Reserve |
45,910,432.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-960,433,981.83 |
| Minority Stockholder's Interest |
30,763,516.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,700,636,785.15 |
| Owner's Equity（Stockholder's Equity） |
2,731,400,301.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,395,495,506.01 |
